在APOE4恒星细胞中,胆固醇介导的溶酶体功能障碍促进了人类大脑组织中的α-Synuclein病理
Louise A Mesentier-Louro1,2,3,4,5,6,7, Camille Goldman1,2,3,4,5,6,7, Alain Ndayisaba6,8,9,10
1Icahn School of Medicine, Mount Sinai, New York, NY, USA.
bioRxiv : the preprint server for biology
|February 20, 2025
概括
APOE4基因在一个新的3D人类大脑模型中加速α-synuclein聚合. 损害脂质降解的星体细胞有助于神经退行性蛋白质的包容.
科学领域:
- 神经科学是一个神经科学.
- 遗传学 遗传学 是一个
- 细胞生物学 细胞生物学
背景情况:
- 神经退行性疾病的特点是蛋白质聚合,与遗传因素,如APOE4加剧tau,粉样蛋白和α-synuclein病理.
- 人类大脑无法进入,这阻碍了对这些蛋白质聚合机制的理解.
研究的目的:
- 开发一个功能性的3D人类大脑模型 (miBrain),整合多种细胞类型,用于研究神经退行.
- 在这个模型中,研究APOE4在α-synuclein翻译后修饰和聚合中的作用.
主要方法:
- 基于诱导多能干细胞 (iPSC) 的3DmiBrain模型的开发,其中包括神经元,神经,髓和脑血管细胞.
- 在APOE4与对照miBrain模型中对α-synuclein酸化和聚合的比较分析.
- 研究星细胞脂质液滴形成对α-synuclein降解的影响.
主要成果:
- APOE4 miBrain模型重复了致病性酸化和α-synuclein聚合的增加,反映了人类大脑病理.
- 在APOE4天体细胞中积累的脂质液滴被发现阻碍了α-synuclein降解.
- 这种损伤导致了α-synuclein转化和神经元内含的播种.
结论:
- miBrain模型为研究人类大脑组织中的蛋白质含量提供了一个强大的平台.
- 星细胞功能障碍,特别是脂肪代谢和胆固醇处理受损,在APOE4相关的神经退行症中起着关键作用.
- 这些发现揭示了与APOE4介导病理的星细胞和胆固醇代谢相关的潜在治疗点.
相关概念视频
01:22Lysosomal Hydrolases
3.7K
Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
3.7K
03:03Amyloid Fibrils
9.2K
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
9.2K
01:26Alzheimer's Disease: Overview
429
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
429